Fund the Future of Digestive Diseases
The wise words of renowned gastroenterologist and GIRF Co-Founder Joseph B. Kirsner, MD, PhD ring even truer today than when he spoke them decades ago:
“We get some of the most wonderful young men and women who… enter medicine with a feeling that they want to help people in trouble and sick people … we must nurture that and sustain it, for there in lies our future.”
In the midst of the chaos of the past 18 months, two things have become clear: the importance of funding medical research and supporting our frontline medical staff. Over and over, they continue to be there for us. Now is the time for us to invest in them.
The Associates Board is investing in the leaders fighting for bold changes in digestive diseases treatment, prevention and care at the UChicago Medicine Digestive Diseases Center.
Join us and fund the future of GI research today.
The Associates Board
Since 1997, the young professionals of the Associates Board have raised more than $500,000 to fund groundbreaking research by future field leaders working to provide relief and hope for patients and families suffering from digestive diseases.
News from the Associates Board
This year, the Associates Board awarded a record $37,575 to four grant recipients. The 2021 cohort includes third-year pediatric Fellow Mora Puertolas, BA, MBBS; second-year pediatric Fellow Julia Kleinhenz, MD; third-year gastroenterology Fellow Ariel Halper Stromberg, MD, PhD; and post-doctoral scholar Madeleine Durkee, PhD.
Hitting a Home Run for GI Research
In 2021, the Associates Board held a drawing for a VIP Cubs experience and raised nearly $1,600 for GI research at the University of Chicago Medicine Digestive Diseases Center.
The Associates Board hosts events throughout the year in support of researchers at the beginning of their careers. Past events include an annual cocktail party and “Team Up for GI Research” spin event. Check back for upcoming events!
Our volunteers are the heart of our mission. Help us prevent, treat, and cure digestive disease.